NRX Pharmaceuticals, Inc. Conversion of Stock, Shares Converted
NRX Pharmaceuticals, Inc. (NRXP) had Conversion of Stock, Shares Converted of 1 shares as of 2024-04-01, per its 10-Q filed 2024-05-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2024-05-14
- 2024-04-01: Conversion of Stock, Shares Converted 1.00 shares.
- 2020-02-12: Conversion of Stock, Shares Converted 132.74K shares.
| Period end | Conversion of Stock, Shares Converted |
|---|---|
| 2024-04-01 | 1.00 shares 10-Q · filed 2024-05-14 |
| 2020-02-12 | 132.74K shares 10-Q/A · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |